Friday, November 12, 2021

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet

Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin. As per phase-three clinical trials data, Covaxin demonstrates 77.8 per cent efficacy against symptomatic COVID-19.

from IndiaTV India: Google News Feed https://ift.tt/3F7nPOd
via
at
Labels:

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Subscribe to: Post Comments (Atom)

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...